SEATTLE, Oct. 17, 2011 /PRNewswire/ - Christopher Henney, Chairman of the Board of Oncothyreon Inc.

HAYWARD, Calif., May 6 /PRNewswire-FirstCall/ -- Anthera Pharmaceuticals, Inc.

NEW YORK, NY, Sept. 4 /PRNewswire-FirstCall/ - (OTCBB: GVBP.OB) - GENova Biotherapeutics, Inc., ("GENova"), a biotechnology company that identifies, acquires, and develops novel drug targets that disrupt the advance of life-threatening diseases, today named Dr. John Savin as its Vice President. Dr.

Western Branded Drug Sales Will Command 54 percent of the Market by 2013, According to a New Report from Decision Resources WALTHAM, Mass., May 13 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that the non-small-cell lung cancer drug market in India will almost double by 2013, growing from $27.7 million in 2008 to $52.1 million in 2013.

BERKELEY HEIGHTS, N.J., Nov. 13, 2008 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc.